{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.526.3.1318","meta":{"versionId":"19","lastUpdated":"2022-03-02T18:04:24.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"PCPI Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-03-02"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1318","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.526.3.1318"}],"version":"20170926","name":"IntoleranceToTamoxifenOrAromataseInhibitorTherapy","title":"Intolerance to Tamoxifen or Aromatase Inhibitor Therapy","status":"active","experimental":false,"date":"2022-03-03T18:46:01-05:00","publisher":"PCPI Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Under Development),(Data Element Scope: Under Development),(Inclusion Criteria: Under Development),(Exclusion Criteria: Under Development)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1384"]}]},"expansion":{"identifier":"urn:uuid:27315a2b-2e11-4cb9-83e7-3040bab3b369","timestamp":"2023-12-11T02:55:14-05:00","total":2,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"292248002","display":"Tamoxifen adverse reaction (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"312961004","display":"Tamoxifen retinopathy (disorder)"}]}}